Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From
(Q88139733)
scientific article published on 23 May 2017
scientific article published on 23 May 2017
Language:
other details
| description | scientific article published on 23 May 2017 |
External Links
| (P356) |
10.1253/CIRCJ.CJ-16-1310
|
| (P698) |
28539539
|